Vivos Therapeutics, Inc. (VVOS) Gross margin 2019–2025
Vivos Therapeutics, Inc. (VVOS) gross margin by fiscal year — reported gross profit divided by reported revenue.
60.4%FY2025 · since FY2019: 76.0% → 60.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 60.4% | +0.4 pp |
| FY2024 | 60.0% | +0.1 pp |
| FY2023 | 59.9% | -2.6 pp |
| FY2022 | 62.5% | -12.1 pp |
| FY2021 | 74.6% | -5.0 pp |
| FY2020 | 79.7% | +3.7 pp |
| FY2019 | 76.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice